Firstsource Solutions Limited (NSE:FSL)
India · Delayed Price · Currency is INR 368.35
-1.50 (-0.41%)
Aug 8, 2025, 3:30 PM IST
Inozyme Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 5,945 | 5,147 | 5,137 | 5,374 | 3,617 | Upgrade |
Depreciation & Amortization | - | 3,101 | 2,412 | 2,431 | 2,239 | 1,782 | Upgrade |
Other Amortization | - | 169.69 | 189.97 | 200.62 | 255.13 | 281.48 | Upgrade |
Loss (Gain) From Sale of Assets | - | 49.98 | 55.91 | 7.2 | 3.1 | 3.82 | Upgrade |
Loss (Gain) From Sale of Investments | - | -68.45 | -62.11 | -47.54 | -30.37 | -18.99 | Upgrade |
Stock-Based Compensation | - | 715.88 | 31.34 | 227.92 | 320 | 208.88 | Upgrade |
Provision & Write-off of Bad Debts | - | 110.31 | 322.64 | 185.36 | 77.95 | 32.75 | Upgrade |
Other Operating Activities | - | 1,932 | 754.62 | -956.59 | 681.9 | 953.38 | Upgrade |
Change in Accounts Receivable | - | -4,209 | -1,546 | -964.92 | -457.28 | -835.2 | Upgrade |
Change in Other Net Operating Assets | - | -735.4 | -865.44 | 1,730 | -1,427 | 3,731 | Upgrade |
Operating Cash Flow | - | 7,011 | 6,441 | 7,950 | 7,036 | 9,756 | Upgrade |
Operating Cash Flow Growth | - | 8.86% | -18.99% | 13.00% | -27.88% | 137.71% | Upgrade |
Capital Expenditures | - | -2,412 | -851.04 | -536.22 | -850.3 | -1,731 | Upgrade |
Sale of Property, Plant & Equipment | - | 175.86 | 0.61 | 21.99 | 121.27 | 35.46 | Upgrade |
Cash Acquisitions | - | -5,099 | - | - | -5,067 | -950 | Upgrade |
Investment in Securities | - | -159.3 | 324.34 | 637.42 | -327.31 | -800.71 | Upgrade |
Other Investing Activities | - | 35.39 | -53.84 | 40.34 | 177.7 | -34.7 | Upgrade |
Investing Cash Flow | - | -7,459 | -579.93 | 163.53 | -5,946 | -3,481 | Upgrade |
Short-Term Debt Issued | - | 5,198 | 1,278 | - | 2,443 | - | Upgrade |
Long-Term Debt Issued | - | 3,382 | - | 50.49 | 3,008 | 1,622 | Upgrade |
Total Debt Issued | - | 8,581 | 1,278 | 50.49 | 5,451 | 1,622 | Upgrade |
Short-Term Debt Repaid | - | - | - | -1,977 | - | -4,200 | Upgrade |
Long-Term Debt Repaid | - | -3,430 | -2,971 | -1,920 | -2,716 | -1,186 | Upgrade |
Total Debt Repaid | - | -3,430 | -2,971 | -3,896 | -2,716 | -5,386 | Upgrade |
Net Debt Issued (Repaid) | - | 5,151 | -1,693 | -3,846 | 2,735 | -3,764 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 82.15 | Upgrade |
Repurchase of Common Stock | - | -362 | - | -139.58 | -462.66 | -652.81 | Upgrade |
Common Dividends Paid | - | -2,759 | -2,406 | -2,384 | -2,384 | -2,038 | Upgrade |
Other Financing Activities | - | -1,804 | -1,535 | -1,064 | -1,468 | -514.28 | Upgrade |
Financing Cash Flow | - | 225.92 | -5,635 | -7,434 | -1,580 | -6,887 | Upgrade |
Foreign Exchange Rate Adjustments | - | 16.46 | 6.23 | 7.26 | 1.85 | 36.08 | Upgrade |
Net Cash Flow | - | -205.62 | 232.34 | 687.2 | -487.96 | -576.07 | Upgrade |
Free Cash Flow | - | 4,599 | 5,590 | 7,414 | 6,185 | 8,025 | Upgrade |
Free Cash Flow Growth | - | -17.72% | -24.61% | 19.86% | -22.92% | 154.24% | Upgrade |
Free Cash Flow Margin | - | 5.76% | 8.82% | 12.31% | 10.45% | 15.80% | Upgrade |
Free Cash Flow Per Share | - | 6.52 | 7.97 | 10.57 | 8.77 | 11.38 | Upgrade |
Cash Interest Paid | - | 1,579 | 1,011 | 787.42 | 580.44 | 514.28 | Upgrade |
Cash Income Tax Paid | - | 1,219 | 717.75 | 655.92 | 944.86 | 698.09 | Upgrade |
Levered Free Cash Flow | - | 2,544 | 3,823 | 6,485 | 2,520 | 6,850 | Upgrade |
Unlevered Free Cash Flow | - | 3,468 | 4,469 | 6,979 | 2,919 | 7,176 | Upgrade |
Change in Net Working Capital | - | 3,610 | 1,665 | -1,135 | 3,485 | -2,898 | Upgrade |
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.